Literature DB >> 90170

Radioimmunoassays for the 36,000-dalton glycoprotein of murine mammary tumor viruses demonstrate type, group, and interspecies determinants.

Y A Teramoto, J Schlom.   

Abstract

Mouse mammary tumor viruses (MMTVs) contain distinct membrane glycoproteins of 52,000 daltons (gp52) and 36,000 daltons (gp36). We report here the development of new radioimmunoassays for gp36, using gp36 purified by hydrophobic chromatography and gel filtration. These assays demonstrate that gp36 has both type-specific and group-specific antigenic determinants. The virus-coded nature of these determinants was shown by utilizing different MMTVs grown in the same feline cell line. Interspecies determinants on gp36 were demonstrated by the observations that (i) MC-MTV (a virus isolate from the Asian rodent Mus cervicolor, and morphologically identical to MMTVs) competed, with an altered slope, in the gp36 radioimmunoassay, and (ii) antisera raised against MC-MTV immunopreciptitated 125I-labeled gp36. The detection of gp36 in spontaneous mammary tumors of several strains of mice also facilitates further studies on the replication of MMTVs and the host's immune response to MMTV-mediated oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90170      PMCID: PMC353455          DOI: 10.1128/JVI.31.2.334-340.1979

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The major polypeptides of the murine-mammary-tumor virus isolated by plant-lectin affinity chromatography.

Authors:  F Westenbrink; W Koornstra; P Bentvelzen
Journal:  Eur J Biochem       Date:  1977-06-01

2.  Structural components of mouse mammary tumor virus. I. Polypeptides of the virion.

Authors:  M J Yagi; R W Compans
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Cellular immunity to autologous breast cancer and RIII-murine mammary tumor virus preparations.

Authors:  M M Black; R E Zachrau; B Shore; A S Dion; H P Leis
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

5.  Synthesis and processing of precursor polypeptides to murine mammary tumor virus structural proteins.

Authors:  J Racevskis; N H Sarkar
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

6.  The relative hydrophobicity of oncornaviral structural proteins.

Authors:  S L Marcus; S W Smith; J Racevskis; N H Sarkar
Journal:  Virology       Date:  1978-05-15       Impact factor: 3.616

7.  Isolation of separate precursor polypeptides for the mouse mammary tumor virus glycoproteins and nonglycoproteins.

Authors:  G Schochetman; C W Long; S Oroszlan; L Arthur; D L Fine
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

8.  Identification of a precursor protein to the major glycoproteins of mouse mammary tumor virus.

Authors:  C Dickson; J P Puma; S Nandi
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

9.  Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses.

Authors:  J N Ihle; J J Domotor; K M Bengali
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

10.  Plasma levels of a viral protein as a diagnostic signal for the presence of mammary tumor: the effect of tumor removal.

Authors:  E Ritzi; D S Martin; R L Stolfi; S Spiegelman
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more
  2 in total

1.  Simultaneous purification of murine mammary tumor virus structural proteins: analysis of antigenic reactivities of native gp34 by radioimmunocompetition assays.

Authors:  S L Marcus; R Kopelman; N H Sarkar
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

2.  Monoclonal antibodies identify individual determinants on mouse mammary tumor virus glycoprotein gp52 with group, class, or type specificity.

Authors:  R J Massey; L O Arthur; R C Nowinski; G Schochetman
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.